Mankind Pharma Limited

NSE: MANKINDHealthcareLot size: 250

Mankind Pharma Limited Open Interest & PCR Analysis

₹2490.00Updated 28 Oct 2026, 03:30 pm IST
PCR
1.18Neutral
Max Pain
₹2480Spot above by ₹10
Total CE OI
899KCall writers
Total PE OI
1.06MPut writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish
AI AnalysisGenerated daily after market close · AI-powered

OI Buildup Pattern

The open interest remains unchanged at 8,98,500 contracts, while the price is flat at ₹2,490, indicating a neutral buildup where neither longs nor shorts are adding pressure. With call open interest at 10,57,750 and put open interest at 8,98,500, the net positioning shows a slight preference for bullish contracts, yet the unchanged total OI suggests limited new directional bets as investors reassess earnings outlook and filings. Since price movement is negligible and open interest is stable, the market appears to be in a holding pattern, awaiting new catalysts before any significant repositioning occurs in response to mixed data.

Put-Call Ratio

The put‑call ratio stands at 1.177, indicating that put contracts slightly outweigh calls, which is a modestly bearish signal in the options market. Compared with yesterday’s 0.826 level, the ratio has risen sharply, reflecting an increase in bearish sentiment or a reduction in call buying over the last session and higher put volume today.

Futures OI

Futures open interest registers zero change, confirming that speculators are not adding fresh positions in the underlying index for this expiry and no new inflow. The flat futures OI, together with the unchanged total OI, underscores a lack of directional conviction among market participants at present.

Data Summary

Overall, the key takeaway is a neutral open interest stance with 8,98,500 contracts unchanged, signaling no significant new positioning for this expiration.

Data as of 2026-10-28

Frequently Asked Questions

What is Mankind Pharma Limited PCR (Put-Call Ratio) today?
Mankind Pharma Limited's current PCR is 1.18. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Mankind Pharma Limited's PCR of 1.18 indicates neutral sentiment.
What is Mankind Pharma Limited OI buildup type today?
Mankind Pharma Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Mankind Pharma Limited?
Mankind Pharma Limited has total CE (call) OI of 898500 contracts and total PE (put) OI of 1057750 contracts for the nearest expiry. The PCR is 1.18.
How is open interest analysis useful for Mankind Pharma Limited trading?
OI analysis for Mankind Pharma Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Mankind Pharma Limited?
Mankind Pharma Limited's max pain is ₹2,480 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.